서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 17 of 17

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2004-12	A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma Sun, Jong-Mu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue; Choe, Kuk Jin; Kim, Noe Kyeong Cancer, Vol.101 No.11, pp.2516-2522	DOI
2006-12	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095	DOI
2007-11	Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer Chie, Eui Kyu; Kim, Kyubo; Noh, Dong-Young; Choe, Kuk Jin; Kim, Tae-You; Im, Seok-Ah; Bang, Yung-Jue; Ha, Sung W. Tumori, Vol.93 No.6, pp.591-596	DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	view file DOI
2010-02	Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.33 No.1, pp.23-27	DOI
2011-01	High serum TGF-alpha predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer Rhee, Jiyoung; Han, Sae-Won; Cha, Yongjun; Ham, Hye Seon; Kim, Hwang-phill; Oh, Do-Youn; Im, Seock-Ah; Park, Jong-Wan; Ro, Jungsil; Lee, Keun Seok; Park, In Hae; Im, Young-Hyuck; Bang, Yung-Jue; Kim, Tae-You Breast Cancer Research and Treatment, Vol.125 No.1, pp.107-114	DOI
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-07	Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer Han, Sae-Won; Cha, Yongjun; Paquet, Agnes; Huang, Weidong; Weidler, Jodi; Lie, Yolanda; Sherwood, Thomas; Bates, Michael; Haddad, Mojgan; Park, In Hae; Oh, Do-Youn; Lee, Keun Seok; Im, Seock-Ah; Bang, Yung-Jue; Ro, Jungsil; Kim, Tae-You PLoS ONE, Vol.7 No.7, p. e0039943	DOI
2012-08	ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue Oncology, Vol.83 No.4, pp.218-227	DOI
2012-12	Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data Lee, Kytmg-Hun; Keam, Bhumsuk; Im, Seock-Ah; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Breast Cancer, Vol.15 No.4, pp.427-433	view file DOI
2013-07	HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.1, pp.109-115	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280
2015-12	Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer Ahn, Soo Kyung; Lee, Han-Byoel; Han, Wonshik; Moon, Hyeong-Gon; You, Jee Man; Kim, Jisun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Noh, Dong-Young Annals of Surgical Oncology, Vol.22, pp.S391-S397	DOI
2016-06	Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Nutrition and Cancer, Vol.68 No.5, pp.750-755	DOI
2020-04	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS Park, Y. H.; Senkus-Konefka, E.; Im, S. -A.; Pentheroudakis, G.; Saji, S.; Gupta, S.; Iwata, H.; Mastura, M. Y.; Dent, R.; Lu, Y. -S.; Yin, Y.; Smruti, B. K.; Toyama, T.; Malwinder, S.; Lee, S. C.; Tseng, L. -M.; Kim, J. H.; Kim, T. -Y.; Suh, K. J.; Cardoso, F.; Yoshino, T.; Douillard, J. -Y. Annals of Oncology, Vol.31 No.4, pp.451-469	DOI

1